Health Trials

Clinical trials

4

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Optilume PoST AppRoval Clinical Evaluation of Andrology ParaMeters

Single-arm, prospective study assessing semen quality after treatment with the Optilume Urethral DCB in men between 22 and 65 years of age.

Participants needed: 34
Trial details
Phase: Phase 4Age: 22-65Biological sex: MaleType: InterventionalSponsor: Urotronic Inc.Updated: Apr 28, 2026Locations: 9
Eligibility criteria

Male subjects between 22 and 65 years of age [+7]

Subjects with a known hypersensitivity to paclitaxel or structurally related com... [+5]

Read more
Status: Recruiting

OPtilume™ BPH Catheter SystEm for Treatment of Men eXperiencing Symptomatic BPH

APEX is a prospective multi-site registry of real-world experience with the Optilume™ BPH Catheter System for treatment of men experiencing symptomatic BPH.

Participants needed: 500
Trial details
Biological sex: MaleType: ObservationalSponsor: Urotronic Inc.Updated: Mar 27, 2026Locations: 9Duration: 2 Years
Eligibility criteria

Unwilling to abstain from sexual intercourse or use a condom for 30 days post-pr... [+4]

Read more
Status: Recruiting

EvaluatioN of Optilume Drug-Coated Balloon for the Endoscopic Treatment of UREteric Strictures

The main objective of this clinical investigation is to assess the safety and feasibility of the Optilume DCB for treatment of ureteric strictures.

Participants needed: 60
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Urotronic Inc.Updated: Mar 9, 2026Locations: 7
Eligibility criteria

Age 18 years or older [+2]

Treatment of the target ureter with incision or balloon dilation within 3 months... [+26]

Read more
Status: Recruiting

Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study

The goal of this clinical trial is to verify the continued safety and effectiveness for the Optilume BPH Catheter System.

Participants needed: 92
Trial details
Age: 50+Biological sex: MaleType: InterventionalSponsor: Urotronic Inc.Updated: Jan 14, 2026Locations: 5
Eligibility criteria

Male subject ≥ 50 years old [+6]

Unwilling to abstain from sexual intercourse or use a condom for 30 days post-pr... [+13]

Read more